Industry News's blog

DMCA.com Protection Status
Industry News's picture
Keywords: 

By the WoundSource Editor

Newport Beach, CA – January 9, 2018 –Ventris Medical, a Newport Beach-based healthcare company, today announced the company’s official launch. The company also is launching its full line of placental allograft products that will be used in surgical and non-surgical applications.

Blog Category: 
Industry News's picture
Keywords: 

By the WoundSource Editors

Suwanee, GA – January 2, 2018 – SANUWAVE Health, Inc. (OTCQB: SNWV) has announced that the US Food and Drug Administration (FDA) has issued its decision on the de novo submission for the dermaPACE® System. Their decision, dated December 28, 2017, permits the marketing of the dermaPACE System as a Class II medical device used for the treatment of Diabetic Foot Ulcers (DFU) in the U.S., the world's largest medical device market. This order by FDA is the culmination of intensive clinical studies by SANUWAVE and diligent work by both SANUWAVE employees and their regulatory partners, Musculoskeletal Clinical Regulatory Advisers (MCRA) in successfully submitting documentation and interacting with FDA during the clearance process.

Blog Category: 
Industry News's picture
Keywords: 

By the WoundSource Editor

Tempe, Arizona - December 5, 2017 Vomaris Innovations, Inc. announced today breakthrough results of the first controlled, preclinical in vivo evidence on the anti-biofilm impact of the company’s bioelectric antimicrobial technology. The study found that the technology can prevent and disrupt biofilm infection and restore functional wound healing. The manuscript, “Electric Field Based Dressing Disrupts Mixed-Species Bacterial Biofilm Infection and Restores Functional Wound Healing,” was published online in the Annals of Surgery. The research was led by Chandan Sen, Ph.D., Professor of Surgery and Director of the Comprehensive Wound Center at The Ohio State University’s Wexner Medical Center.

Blog Category: 
Industry News's picture
Keywords: 

by The Wound Healing Foundation

This update from the Wound Healing Foundation (WHF) provides an overview of current and future educational, research and community-based initiatives in wound care. Recent WHF activities and opportunities include participation in international dialogue and meetings, as well as the ongoing efforts to advance and support scientific research in the field of wound management.

Blog Category: 
Industry News's picture
Keywords: 

By the WoundSource Editors

Springdale, OH – November 14, 2017 –National Association of Directors of Nursing Administration (NADONA) recently announced a new public/private partnership with Ocean Spray Cranberries designed to target Antibiotic Resistance and improve Antibiotic Stewardship efforts in America's Long-Term Care and Post-Acute Care healthcare facilities. This partnership is focused on clinical education, research, and public policy and advocacy to improve Antibiotic Stewardship across the continuum of care. As part of this partnership, Ocean Spray is the exclusive sponsor of the new NADONA Antibiotic Stewardship Certificate of Mastery, an innovative webinar series to assist healthcare facilities with implementing the Centers for Disease Control Core Elements, and a new annual award recognizing the most progressive Antibiotic Stewardship program nationally and also an Antibiotic Stewardship leader nominated by their facility. The inaugural winners will be announced at the 2018 NADONA Annual Conference being held June 22-27, 2018.

Blog Category: 
Industry News's picture
Keywords: 

By The Alliance of Wound Care Stakeholders

In their quarterly Alliance Advocacy Update, the Alliance of Wound Care Stakeholders (Alliance) provides an update on their ongoing advocacy initiatives on behalf of their clinical association members to ensure access, coverage and payment to wound care procedures and technologies for patients and providers.

Blog Category: 
Industry News's picture

By the WoundSource Editors

San Diego, CA – October 3, 2017 – CogenDx, the genetics brand of Millennium Health, LLC, announced the launch of its newest test offering, DxWound. The test uses DNA-based technology to provide accurate, sensitive detection of an array of microbes, including aerobic and anaerobic bacteria, fungi, plus antibiotic resistance genes. Results from the tests equip clinicians to rapidly and accurately identify potential pathogens causing infections and select antibiotics with greater likelihood for efficacy.

Blog Category: 
Industry News's picture

By the WoundSource Editors

Chicago, IL – October 23, 2017 – Global medical technology company Hill-Rom (NYSE: HRC) today announced the launch of a new medical-surgical bed solution for hospitals that offers optimized patient safety, enhanced patient satisfaction and advanced caregiver-focused technology. The new Hill-Rom® Centrella™ Smart+ bed is available now in the U.S., and in Canada in November.

Blog Category: 
Industry News's picture

Marietta, GA – October 11, 2017 – MiMedx Group, Inc. (NASDAQ: MDXG), a leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare, announced today that the latest peer-reviewed clinical study of MiMedx dehydrated human amnion/chorion membrane ("dHACM") allografts has been published in the International Wound Journal.

Blog Category: 
Industry News's picture
Keywords: 

By The Alliance of Wound Care Stakeholders

October 4, 2017 – A new study published online in the International Society For Pharmacoeconomics and Outcomes Research's (ISPOR) Value in Health journal demonstrates the economic impact of chronic nonhealing wounds in Medicare patients. The findings highlight the need for Federal research funding, quality measures and reimbursement models that are relevant to wound care. Such measures are not currently included under Centers for Medicare and Medicaid Services (CMS) payment policies, including the Medicare Access and CHIP Reauthorization Act (MACRA).

Blog Category: 

Important Notice: The contents of the website such as text, graphics, images, and other materials contained on the website ("Content") are for informational purposes only. The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. The content is not intended to substitute manufacturer instructions. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or product usage. Refer to the Legal Notice for express terms of use.